Article: FDA gives Avanir OK to test experimental, allergy and asthma drug. (Biotech).(Brief Article)

OK For Avanir: Avanir Pharmaceuticals, which sells the and-herpes cream Abreva, said it won FDA permission to test an experimental allergy and asthma drug for its safety in healthy individuals.

The compound known as AV 13358 aims to pre-empt the release of mediators involved in asthma and allergy, Avanir said. Existing drugs such as antihistamines only suppress symptoms of allergy, but they can't stop the progression of disease, Avanir said.

"The initiation of this ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!